Investigational Drug Information for BLU-5937
✉ Email this page to a colleague
What is the development status for investigational drug BLU-5937?
BLU-5937 is an investigational drug.
There have been 9 clinical trials for BLU-5937.
The most recent clinical trial was a Phase 1 trial, which was initiated on October 1st 2022.
The most common disease conditions in clinical trials are Cough, Eczema, and Dermatitis, Atopic. The leading clinical trial sponsors are Bellus Health Inc and [disabled in preview].
There are four US patents protecting this investigational drug and fifty-two international patents.
Summary for BLU-5937
| US Patents | 4 |
| International Patents | 52 |
| US Patent Applications | 33 |
| WIPO Patent Applications | 4 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 1 (2022-10-01) |
| Vendors | 7 |
Recent Clinical Trials for BLU-5937
| Title | Sponsor | Phase |
|---|---|---|
| Evaluation of the Effect of Rifampin and Rabeprazole on the Pharmacokinetics of Camlipixant | Bellus Health Inc | Phase 1 |
| Assessment of the Pharmacokinetics of BLU-5937 Extended Release Formulation | Bellus Health Inc | Phase 1 |
| A 52-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough | Bellus Health Inc | Phase 3 |
Clinical Trial Summary for BLU-5937
Top disease conditions for BLU-5937
Top clinical trial sponsors for BLU-5937
US Patents for BLU-5937
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| BLU-5937 | ⤷ Try a Trial | Selective P2X3 modulators | BELLUS HEALTH COUGH INC. (Laval, Quebec, CA) NEOMED INSTITUTE (Montreal, Quebec, CA) | ⤷ Try a Trial |
| BLU-5937 | ⤷ Try a Trial | Imidazopyridine compounds and uses thereof | Neomed Institute (Montreal, Quebec, CA) | ⤷ Try a Trial |
| BLU-5937 | ⤷ Try a Trial | Method of treatment of chronic cough administering orvepitant in combination with other therapeutic agents | NeRRe Therapeutics Limited (Herts, GB) | ⤷ Try a Trial |
| BLU-5937 | ⤷ Try a Trial | Imidazopyridine compounds and uses thereof | ⤷ Try a Trial | |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for BLU-5937
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| BLU-5937 | Australia | AU2018342751 | 2037-09-18 | ⤷ Try a Trial |
| BLU-5937 | Canada | CA3076150 | 2037-09-18 | ⤷ Try a Trial |
| BLU-5937 | China | CN111601601 | 2037-09-18 | ⤷ Try a Trial |
| BLU-5937 | European Patent Office | EP3684368 | 2037-09-18 | ⤷ Try a Trial |
| BLU-5937 | Israel | IL273348 | 2037-09-18 | ⤷ Try a Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
